-
Scientists propose method of producing water-soluble fullerene compounds
europeanpharmaceuticalreview
March 19, 2020
A new single-step technique has been developed which could enable the synthesis of water-soluble fullerene compounds for use in pharma.
-
PrEP to be available in England from April
pharmatimes
March 18, 2020
From April, the Department of Health and Social Care will ensure that everyone at high risk of contracting HIV will receive PrEP from their local sexual health clinic.
-
Distributing HIV drugs using mobile vans increases viral suppression, finds study
europeanpharmaceuticalreview
March 13, 2020
Researchers have shown that using mobile vans to deliver and dispense HIV drugs in South Africa and Uganda helps to combat the disease.
-
Second patient cured of HIV using stem cell therapy
europeanpharmaceuticalreview
March 12, 2020
Researchers report that a patient who underwent stem-cell transplantation and a chemotherapy drug regimen has been cured of HIV.
-
Drug delivery method leads to sustained HIV antibody production in study
europeanpharmaceuticalreview
March 11, 2020
Using AAV-based technology to deliver mAbs in a Phase I trial, researchers report that participants successfully developed antibodies against HIV.
-
ViiV Healthcare and UNC-Chapel Hill expand HIV cure partnership
pharmaceutical-technology
March 11, 2020
Glaxo-Smith-Kline’s human immunodeficiency virus (HIV) specialist company ViiV Healthcare has renewed its public-private research partnership with University of North Carolina at Chapel Hill (UNC-Chapel Hill) for another five years with a $20m investment.
-
Neural Tube Defect Prevalence 7.0 Per 10,000 in HIV-Exposed
drugs
January 20, 2020
The prevalence of neural tube defects (NTDs) is 7.0 per 10,000 live births in HIV-exposed pregnancies, which is similar to the prevalence in the general population ...
-
Early Antiretroviral Therapy May Not Achieve HIV Remission in Infants
drugs
January 20, 2020
Starting antiretroviral therapy (ART) for HIV-infected infants within hours of birth does not seem to result in a higher proportion of infants who attain and sustain viral suppression on ART, according to a study published online January in EClinicalMedic
-
HIV+ Patients Lose Immunity to Smallpox Despite Vaccination
drugs
January 19, 2020
HIV-infected patients lose immunity to smallpox despite childhood vaccination and immune reconstitution with antiretroviral therapy, according to a study published online December in The Journal of Infectious Diseases.
-
HIV-Infected Newborns Can Wait Awhile for Treatment
drugs
January 16, 2020
The effectiveness of antiretroviral therapy (ART) in newborns with HIV is similar whether it begins within days or within weeks, a new study finds.